Prolific Machines is a biotech company developing cell technologies to redefine how cells are produced for a sustainable and healthy future.
Prolific Machines is a biotech company developing cell technologies to redefine how cells are produced for a sustainable and healthy future. It combines cutting-edge technologies to enable cell production at a new scale. The company was founded in 2020 and is based in San Francisco, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 7, 2022 | Convertable Note | — | 2 | — | — | Detail |
Sep 14, 2022 | Series A | $42M | 12 | Breakthrough Energy Ventures | — | Detail |
Nov 19, 2021 | Seed | — | 1 | — | — | Detail |
Mar 22, 2021 | Seed | — | 2 | — | — | Detail |
Jul 14, 2020 | Convertable Note | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Breakthrough Energy Ventures | Yes | Series A |
IndieBio | — | Convertable Note |
SOSV | — | Convertable Note |
Baruch Future Ventures | — | Series A |
Breyer Capital | — | Series A |
David Adelman | — | Series A |
David Rubenstein | — | Series A |
Frederick Blackford | — | Series A |
Jacob Poliskin | — | Series A |
Mark Cuban | — | Series A |